Year archive

BIOXYNE LIMITED — 2025 filings

All 71 regulatory filings released by BIOXYNE LIMITED (BXN) in 2025, sourced directly from the official regulator.

71 Filings

2025 Period

2025 filings (71)

Filing	Released	Lang
Application for quotation of securities - BXN 7 pages 20.7KB Regulatory Filings	2025-12-23	English
Notification regarding unquoted securities - BXN 6 pages 19.0KB Regulatory Filings	2025-12-23	English
Change of Directors Interest Notice X 2 4 pages 261.1KB Regulatory Filings	2025-12-23	English
Notification regarding unquoted securities - BXN 5 pages 16.7KB Regulatory Filings	2025-12-17	English
Application for quotation of securities - BXN 6 pages 19.1KB Regulatory Filings	2025-12-14	English
Application for quotation of securities - BXN 6 pages 19.6KB Regulatory Filings	2025-12-14	English
Cleansing Notice 1 page 187.5KB Regulatory Filings	2025-12-14	English
Directors Change of Interest Notice X 2 4 pages 258.8KB Regulatory Filings	2025-12-14	English
Supply Agreement Secured - Central American Cannabis Markets 3 pages 260.5KB Regulatory Filings	2025-12-10	English
BXN Strengthens Financial Leadership - KEY CFO Appointment 2 pages 245.2KB Regulatory Filings	2025-12-01	English
BXN Ships Australian Made MDMA to Vic Gov Hospital Trial 3 pages 312.1KB Regulatory Filings	2025-11-25	English
CEO Address BXN Annual General Meeting 4 pages 250.4KB Regulatory Filings	2025-11-25	English
Results of Meeting 4 pages 324.6KB Regulatory Filings	2025-11-25	English
Funding from SOSE to Establish UK GMP Manufacturing Facility 3 pages 226.6KB Regulatory Filings	2025-11-16	English
BXN Releases Australian Made GMP MDMA 3 pages 192.6KB Regulatory Filings	2025-11-10	English
BLS to Manufacture and Distribute Curaleaf International MID 3 pages 248.9KB Regulatory Filings	2025-11-02	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 448.5KB Regulatory Filings	2025-10-29	English
Presentation on FY2025 Quarter 1 Results 11 pages 742.8KB Regulatory Filings	2025-10-29	English
Application for quotation of securities - BXN 7 pages 20.1KB Regulatory Filings	2025-10-26	English
Change of Director Interest Notice X 2 4 pages 235.0KB Regulatory Filings	2025-10-26	English
Notice of Annual General Meeting/Proxy Form 52 pages 917.0KB Regulatory Filings	2025-10-26	English
Letter to Shareholders re Annual General Meeting 2 pages 277.3KB Regulatory Filings	2025-10-26	English
Bioxyne Lists on Frankfurt Stock Exchange 4 pages 250.2KB Regulatory Filings	2025-10-12	English
US Cannabis Regulatory Developments - Implications for BXN 2 pages 184.3KB Regulatory Filings	2025-09-30	English
Annual Report to shareholders 69 pages 4.9MB Regulatory Filings	2025-09-29	English
Appendix 4G and Corporate Governance Statement 28 pages 733.2KB Regulatory Filings	2025-09-29	English
Initial German Purchase Orders and Import Permits 2 pages 173.3KB Regulatory Filings	2025-09-14	English
FY 2025 Results Webinar 9.30am 1 September 2025 2 pages 177.4KB Regulatory Filings	2025-08-31	English
Preliminary Final Report 37 pages 1.5MB Regulatory Filings	2025-08-28	English
FY2025 Results Presentation 23 pages 2.4MB Regulatory Filings	2025-08-28	English
BXN Full Year 2026 Guidance 3 pages 171.8KB Regulatory Filings	2025-08-28	English
Statement of Claim 1 page 123.4KB Regulatory Filings	2025-08-26	English
30 June 2025 Appendix 4C Revised 6 pages 318.3KB Regulatory Filings	2025-08-17	English
Application for quotation of securities - BXN 7 pages 20.6KB Regulatory Filings	2025-08-10	English
Cleansing Notice 1 page 184.9KB Regulatory Filings	2025-08-10	English
Bioxyne Updated Investor Presentation 20 pages 2.2MB Regulatory Filings	2025-07-28	English
Change of Shareholder Interest Notice 3 pages 149.1KB Regulatory Filings	2025-07-27	English
Change in substantial holding 3 pages 166.7KB Regulatory Filings	2025-07-27	English
Ceasing to be a substantial holder 3 pages 160.3KB Regulatory Filings	2025-07-27	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 488.2KB Regulatory Filings	2025-07-23	English
Webinar 28 July 2025 5.30pm AEST 2 pages 177.6KB Regulatory Filings	2025-07-22	English
Director Change of Interest Notice Revised 2 pages 193.7KB Regulatory Filings	2025-07-10	English
Change of Director's Interest Notice 2 pages 236.8KB Regulatory Filings	2025-07-09	English
Investor Presentation Update 14 pages 1.7MB Regulatory Filings	2025-06-18	English
Certificate GMP Compliance EU, UK, Singapore & Canada 3 pages 167.7KB Regulatory Filings	2025-06-17	English
Enters German Market Euro3.2m Manufacturing & Supply Agmt 3 pages 332.4KB Regulatory Filings	2025-06-17	English
Webinar Update - Reset to 19 June 2025 3 pages 93.2KB Regulatory Filings	2025-06-17	English
FY25 Revenue Guidance Upgrade 3 pages 182.8KB Regulatory Filings	2025-06-11	English
Bioxyne to Host Webinar 18 June 2025 at 5PM AEST 2 pages 182.3KB Regulatory Filings	2025-06-11	English
Invitation to Investor Webinar 1 May 2025 at 4PM AEST 3 pages 264.0KB Regulatory Filings	2025-04-29	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 551.9KB Regulatory Filings	2025-04-27	English
Notification regarding unquoted securities - BXN 6 pages 20.8KB Regulatory Filings	2025-04-06	English
Notification regarding unquoted securities - BXN 6 pages 20.5KB Regulatory Filings	2025-04-06	English
Notification regarding unquoted securities - BXN 6 pages 20.5KB Regulatory Filings	2025-04-06	English
BXN Signs Exclusive $7m Manufacturing and Supply Agreement 5 pages 226.9KB Regulatory Filings	2025-04-02	English
Prof Michael Barnes MD, FRCP Joins BXN Advisory Board 5 pages 230.5KB Regulatory Filings	2025-04-02	English
Application for quotation of securities - BXN 6 pages 18.3KB Regulatory Filings	2025-03-26	English
Cleansing Notice 1 page 186.4KB Regulatory Filings	2025-03-26	English
Bioxyne Raises A$3 million in Capital Raise 3 pages 288.0KB Regulatory Filings	2025-03-20	English
Proposed issue of securities - BXN 6 pages 21.3KB Regulatory Filings	2025-03-20	English
Proposed issue of securities - BXN 5 pages 18.4KB Regulatory Filings	2025-03-20	English
Proposed issue of securities - BXN 5 pages 18.3KB Regulatory Filings	2025-03-20	English
Pause in Trading 1 page 116.1KB Regulatory Filings	2025-03-18	English
Trading Halt 2 pages 229.3KB Regulatory Filings	2025-03-18	English
Bioxyne Investor Webinar 5 March 3 pages 265.4KB Regulatory Filings	2025-03-03	English
Half Yearly Report and Accounts 31 pages 2.4MB Regulatory Filings	2025-02-27	English
BXN H1 FY25 Results Presentation 23 pages 2.5MB Regulatory Filings	2025-02-27	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 552.0KB Regulatory Filings	2025-01-27	English
Quarterly Activities Report December 2024 Revised 11 pages 519.6KB Regulatory Filings	2025-01-27	English
Revenue Guidance 3 pages 294.2KB Regulatory Filings	2025-01-22	English
Addendum to Presentation dated 18 November 2024 2 pages 201.7KB Regulatory Filings	2025-01-13	English

Filings by year

2026 28 filings
2025 71 filings
2024 48 filings
2023 40 filings
2022 26 filings
2021 18 filings
2020 13 filings
2019 18 filings
2018 34 filings
2017 58 filings
2016 34 filings
2015 19 filings
2014 36 filings
2013 37 filings
2012 33 filings
2011 26 filings
2010 15 filings
2009 26 filings
2008 45 filings
2007 17 filings
2006 23 filings
2005 24 filings
2004 40 filings
2003 100 filings
2002 11 filings